Tumor-infiltrating CD8+ T cells and CD68+ TAMs in resected gastric cancer are predictive of the postoperative prognosis and benefits of adjuvant chemotherapy (7), whereas FOXP3+ T-cell infiltration is associated with worse outcomes (25). The gene discussed is FOXP3; the disease is neoplasm.